U.S Catheters Market - Forecast(2025 - 2031)

U.S Catheters Market Overview:

U.S Catheters Market size is estimated to reach US$2.4 billion by 2030, growing at a CAGR of 5.5% during the forecast period 2024-2030. Several critical factors are driving demand and innovation in the U.S. catheter market. As the population ages, increased catheter use results from age related health issues, and the rising prevalence of chronic diseases such as diabetes and cardiovascular diseases necessitate frequent interventions. Some technological advancements such as antimicrobial coatings and smart catheters, make patient safer and more efficient during operations. Catheter adoption increases with the rise in surgical procedures, especially minimally invasive ones. Additionally, home healthcare growth enables long term management of conditions that require catheters. Finally, demand for advanced, infection resistant catheter technologies is driven by heightened awareness and infection risk mitigation measures. All these factors contribute to the growth of the market.
Two major trends that drive the U.S. catheter market are the adoption of the advanced technology and the increasing shift towards outpatient and home healthcare. A PubMed Central study highlights that advanced catheter, such as antimicrobial impregnated designs, have been effective in reducing colonization of central venous catheters, and could therefore reduce infection risks for high-risk patients. At the same time, demand for home healthcare is increasing. The Bureau of Labor Statistics projects employment of home health and personal care aides will grow by 21 % from 2023 to 2033, or about 718,900 annual openings. The growth reflects the rising dependence on home based medical care, a demand for portable, user-friendly catheters to manage chronic conditions away from hospital settings.

Market Snapshot: 

U.S Catheters Market - Report Coverage:

The “U.S Catheters Market Report - Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the U.S Catheters Market.

COVID-19 / Ukraine Crisis - Impact Analysis:  

•    The U.S. catheters market was highly affected by the COVID 19 pandemic due to disrupted supply chains and the altered healthcare priorities. As hospitals were overwhelmed by COVID-19 cases, demand for some types of catheters fell, and elective procedures, including non-urgent catheterizations, were postponed or canceled. But the sudden rise of critically ill patients who needed to be put on intensive care resulted in a rise in the demand for central venous catheters and Foley catheters. Additionally, manufacturing hurdles like work force shortages and lockdown constraints further confused creation and conveyance, causing momentary absence of supplies and postpones in commercial development amid the top of the pandemic.

•    Russia-Ukraine war aggravated problems in the U.S. catheters market by disrupting the global supply chain and raising production costs. The conflict also reduced output of Ukraine, an important source of medical-grade raw materials and electronic components which are used in catheter manufacturing. The transportation routes were also affected, but it worsened costs and elongated imports. Higher prices due to geopolitical instability were behind the rise of the catheters costs on account of raw materials and energy costs. Taken together, these factors contributed to the pressures on the U.S. market that were already in place, and slowed its recovery post pandemic.

Key Takeaways

Cardiovascular Catheters is the Largest Segment

The U.S. catheters market is dominated by cardiovascular catheters because of the prevalence of heart disease, a serious health problem in the country. Provisional data from the Centers for Disease Control and Prevention (CDC) show that heart disease was the third leading cause of death in the United States in 2023, behind cancer and unintentional injury, killing 680,909 people. This alarming statistic shows the serious concern of the efforts needed to develop advanced diagnostic and treatment solutions like cardiovascular catheters. In cardiac catheterization procedures, in which contrast dye is injected into coronary arteries to see blockages with X-ray imaging, these devices are essential. By doing this, CVG Cares emphasizes, it makes it easier for physicians to accurately diagnose heart attacks and make treatment plans. This segment's market leadership has been cemented further as catheters gain greater dependence on minimally invasive techniques and technological innovations. With more and more people falling victim to cardiac conditions, cardiovascular catheters are still necessary to help improve patient outcomes across the United States.

Silicone Leads the Market

The U.S. catheters market is dominated by silicone segment on account of its hypoallergenic properties, tissue compatibility and enhanced comfort for patients. Byram Healthcare says silicone catheters are particularly good for people with sensitive skin because they’re less likely to cause allergic reactions than latex. The smooth surface and flexibility also facilitate insertion, which is less urethral irritating and painful, especially for patients who use clean intermittent self-catheterization. In addition, the silicone catheters have lower rates of encrustation and are more tissue friendly than latex. Silicone catheters are designed for short term and long-term use, sterile water for short term use and glycerine solutions for long term use to prevent fluid diffusion, says Bactiguard. Also, Willead Medical says silicone catheters have larger inner lumens for better efficiency; come in different sizes with colour-coded systems for ease of use. Taken together, these advantages make silicone the dominant material in this market.

Chronic Diseases

The catheters market is driven by the growing prevalence of chronic diseases in the United States, which often require catheter based medical interventions. The US Department of Health and Human Services estimates that at least one in three Americans or approximately 129 million people have at least one major chronic disease, such as heart disease, cancer, diabetes, obesity, or hypertension. More alarming stats is that 42% of people have two or more chronic conditions and 12% have five or more. Five of the top ten leading causes of death in the U.S. are chronic diseases, which underscore their importance to public health. These conditions have been on the rise steadily over the past two decades, and we expect that trend to continue. In addition, managing chronic diseases is a huge burden on the health care system, accounting for 90% of the $4.1 trillion annual health care expenditure. The demand for advanced medical care which is greatly experienced in catheters diagnostic and therapeutic procedures, increases the adoption.

Aging Population

Ageing population in the United States is a major driver for the catheters market because older people are more susceptible to catheter-based treatments as a result of age-related health conditions. The Population Reference Bureau estimates that by 2050, the number of Americans aged 65 and older will more than triple from 58 million in 2022 to 82 million, a 47% increase. This demographic shift will lead to an increase in the prevalence of chronic conditions, including cardiovascular diseases, urinary disorders and neurovascular ailments, which need catheterization for diagnosis, treatment or long-term management. The Population Reference Bureau also reports that the median age of the U.S. population increased from 30.0 in 1980 to 38.9 in 2022 and that many states have a median age over 40. A growing proportion of the older adults and their higher risk of medical complication are key market drivers for the elderly conveniently designed catheter solutions.

Catheter Complications

A major challenge in the U.S. catheter market is the potential complications associated with catheter use, as outlined by MedlinePlus. The complications of these infections (such as urinary tract infections (UTI and blood infections (septicemia) can be serious and potentially detrimental to the patient’s health and impact costs to the healthcare industry. Severe problems can develop from long term catheter use including kidney damage, bladder stones, and in rare cases bladder cancer. In addition, patients may have allergic reactions to latex catheters, hematuria (blood in the urine), or urethral injury, which will be uncomfortable and require other additional medical intervention. Adoption of catheters, especially for long term use, is complicated by these risks and require stringent safety measures. Innovation in materials and designs respond to the need to address these complications, such as antimicrobial coatings and non-latex options, but infection control and patient safety are essential primary complications. These problems highlight the criticality of sufficient education, monitoring and strong technological enhancements to minimise risks and enhance patient outcomes. 
 
Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the U.S Catheters Market. The top 10 companies in the U.S Catheters Market are:
1.    Medtronic
2.    Boston Scientific Corporation
3.    Abbott Laboratories
4.    Teleflex Incorporated
5.    Becton, Dickinson and Company (BD)
6.    Edwards Lifesciences
7.    Cook Medical
8.    Cardinal Health
9.    Stryker Corporation
10.    AngioDynamics

Scope of Report: 

For more Lifesciences and Healthcare Market reports, please click here